On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival. For the fourth consecutive year, the American Association for Cancer Research (AACR) was a sponsor of the community event, giving eager kids and their families the opportunity to learn about science with hands-on experiments and activities.Read More
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum to present and discuss the latest breakthroughs in cutting-edge basic, translational, and clinical cancer research. As always, the meeting attracted some of the best minds in research and medicine, representing many facets of cancer care. Researchers, physician-scientists, policymakers, advocates, and industry representatives all played important roles in exchanging information over the course of a dynamic Annual Meeting program.Read More
Like many Americans, Dr. Jill Biden has been personally affected by cancer. Friends, her parents, and her son Beau have all died of the disease, fueling her desire to fight for better treatments.
She and her husband, former Vice President Joe Biden, established the Biden Cancer Initiative to build upon the work begun as part of the Cancer Moonshot Initiative in 2016. Dr. Biden attended the American Association for Cancer Research Annual Meeting 2019 on Sunday to share some of the progress that has been made, and to discuss how collaboration will be important in securing future progress.Read More
Twenty years ago, the American Association for Cancer Research launched Women in Cancer Research (WICR), a membership group designed to recognize the scientific achievements of female cancer scientists and provide support in their career endeavors.
The group has thrived for the past two decades, increasing the visibility of women in cancer research, creating professional development opportunities for female investigators-in-training, and growing into a community in which women can discuss the challenges and successes of female scientists.Read More
Stepping onto the exhibit floor at an Annual Meeting poster session is a memorable experience. Row upon row of colorful posters beckon, and the chatter of thousands of people fills the room.
During the upcoming American Association for Cancer Research (AACR) Annual Meeting in Atlanta, 5,167 posters will be presented over the course of six poster sessions. These posters represent 10 major areas of scientific research, plus two policy tracks.Read More
On February 4, 2019, organizations around the globe will come together to recognize World Cancer Day, bringing awareness to the immense burden of cancer that continues to be felt throughout the world. Joining the global community in showing support to all those affected by cancer, the American Association for Cancer Research (AACR) raises awareness about cancer and cancer research by educating the public about cancer, both in the United States and internationally.Read More
Back for the new year, here are the editors’ selections for the January issues of the eight scientific journals published by the American Association for Cancer Research (AACR). Featured research highlights a wide variety of cancer-related topics, spanning from preclinical therapeutic strategies to cancer prevention. All articles summarized here are freely available for a limited time.Read More
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors’ Picks, a monthly collection of articles selected by the editors of the eight scientific journals published by the American Association for Cancer Research (AACR). To wrap up the year, here are the editors’ choices for December. As always, these articles are freely available for a limited time.Read More
Every month, the editors from the eight scientific journals published by the American Association for Cancer Research (AACR) select one “must read” article from each issue. Highlighted research encompasses a wide variety of cancer-related discoveries, including basic scientific investigation and epidemiological studies. Read on to learn about this month’s selections, which are freely accessible for a limited time.Read More
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the disease.
Neither did his local urologist in rural North Carolina.
Within three years, Lawing’s cancer metastasized. His local doctor referred him to a specialist in Charlotte. Under his care, Lawing began a clinical trial of an immunotherapeutic drug. His cancer stabilized. Over the past two decades, he has experienced several recurrences of cancer, but a steady stream of newly approved treatments, most recently the immunotherapeutic Opdivo (nivolumab), have kept his disease under control. He is currently monitored with quarterly CT scans, but is taking no additional medication and experiences no symptoms or side effects.Read More